Showing results (51-60 of 67) with videos related to

Sort By:
Pageof 7
Lupus|June 10, 2024
The additional role of anti-nucleosome antibodies in the prediction of renal damage in systemic lupus erythematosus based on CSTAR (XXV)Yufang Ding, Yangzhong Zhou, Jiuliang Zhao, et al.
Clinical and Experimental Rheumatology|September 5, 2022
Early recognition of catastrophic antiphospholipid syndrome in patients with antiphospholipid syndrome based on a Chinese cohort studyCan Huang, Yuan Zhao, Xinping Tian, et al.
Frontiers in Medicine|October 18, 2021
Clinical Characteristics and Prognoses of Patients With Systemic Lupus Erythematosus Hospitalized for Pulmonary InfectionsYanli Yang, Hui Jiang, Chuhan Wang, et al.
Autoimmunity Reviews|September 7, 2023
Efficacy and safety of Janus kinase inhibitors in systemic and cutaneous lupus erythematosus: A systematic review and meta-analysisLeyao Ma, Liying Peng, Jiuliang Zhao, et al.
Clinical Rheumatology|January 27, 2022
The role of anti-ribosomal P autoantibodies in the prediction of neuropsychiatric damage in systemic lupus erythematosus based on CSTAR cohort (XIV)Yufang Ding, Jiuliang Zhao, Junyan Qian, et al.
Lupus Science & Medicine|January 4, 2022
Sirolimus versus tacrolimus for systemic lupus erythematosus treatment: results from a real-world CSTAR cohort studyNan Jiang, Mengtao Li, Hongfeng Zhang, et al.
Annals of the Rheumatic Diseases|April 17, 2025
The Prospective Registry of MyositIS (PROMIS): I. Next-generation sequencing identifies HLA-DQA1 as a novel genetic risk of anti-MDA5 antibody-positive dermatomyositisXinzhuang Yang, Chen Yu, Xiuling Zhang, et al.
Therapeutic Advances in Respiratory Disease|November 8, 2024
Real-world therapeutic performance of pirfenidone for connective tissue disease-associated interstitial lung diseasesXueting Yuan, Chen Yu, Shengyun Liu, et al.
Clinical Rheumatology|June 7, 2025
Management of newly diagnosed lupus nephritis in China: An implementation study based on the 2023 EULAR recommendationsWei Bai, Yinli Gui, Jia Liu, et al.
Rheumatology and Immunology Research|July 3, 2025
Sirolimus versus mycophenolate mofetil for the treatment of lupus nephritis: Results from a real-world CSTAR cohort studyWei Bai, Liying Peng, Yinli Gui, et al.
Pageof 7